98 related articles for article (PubMed ID: 12910716)
1. [Effects of NaBT and NSAIDs on colorectal adenoma-carcinoma cells].
Zhang Z; Ouyang Q; Gan H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):544-5, 593. PubMed ID: 12910716
[TBL] [Abstract][Full Text] [Related]
2. [The effects of butyrates and non-steroidal anti-inflammatory agents on HT-29 colonic carcinoma cells].
Zhang Z; Ouyang Q; Gan H
Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):153-5. PubMed ID: 11940312
[TBL] [Abstract][Full Text] [Related]
3. Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells.
Zhang ZH; Ouyang Q; Gan HT
World J Gastroenterol; 2004 Oct; 10(20):2954-7. PubMed ID: 15378772
[TBL] [Abstract][Full Text] [Related]
4. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
Andrews J; Djakiew D; Krygier S; Andrews P
Cancer Chemother Pharmacol; 2002 Oct; 50(4):277-84. PubMed ID: 12357301
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.
Shiff SJ; Koutsos MI; Qiao L; Rigas B
Exp Cell Res; 1996 Jan; 222(1):179-88. PubMed ID: 8549662
[TBL] [Abstract][Full Text] [Related]
7. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Crew TE; Elder DJ; Paraskeva C
Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
[TBL] [Abstract][Full Text] [Related]
8. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
9. Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs.
Hofmanová J; Vaculová A; Koubková Z; Hýzd'alová M; Kozubík A
Mol Nutr Food Res; 2009 May; 53 Suppl 1():S102-13. PubMed ID: 19156717
[TBL] [Abstract][Full Text] [Related]
10. Interaction of polyunsaturated fatty acids and sodium butyrate during apoptosis in HT-29 human colon adenocarcinoma cells.
Hofmanová J; Vaculová A; Lojek A; Kozubík A
Eur J Nutr; 2005 Feb; 44(1):40-51. PubMed ID: 15309463
[TBL] [Abstract][Full Text] [Related]
11. NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
Yeh RK; Chen J; Williams JL; Baluch M; Hundley TR; Rosenbaum RE; Kalala S; Traganos F; Benardini F; del Soldato P; Kashfi K; Rigas B
Biochem Pharmacol; 2004 Jun; 67(12):2197-205. PubMed ID: 15163551
[TBL] [Abstract][Full Text] [Related]
12. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines.
Elder DJ; Hague A; Hicks DJ; Paraskeva C
Cancer Res; 1996 May; 56(10):2273-6. PubMed ID: 8625297
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
[TBL] [Abstract][Full Text] [Related]
14. The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation.
Hýzd'alová M; Hofmanová J; Pacherník J; Vaculová A; Kozubík A
Cytokine; 2008 Oct; 44(1):33-43. PubMed ID: 18662886
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
Dial EJ; Doyen JR; Lichtenberger LM
Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells.
Onoda T; Ono T; Dhar DK; Yamanoi A; Fujii T; Nagasue N
J Lab Clin Med; 2004 Apr; 143(4):207-16. PubMed ID: 15085079
[TBL] [Abstract][Full Text] [Related]
17. Co-inhibition of cyclooxygenase-2 and dihydropyrimidine dehydrogenase by non-steroidal anti-inflammatory drugs in tumor cells and xenografts.
Réti A; Pap E; Zalatnai A; Jeney A; Kralovánszky J; Budai B
Anticancer Res; 2009 Aug; 29(8):3095-101. PubMed ID: 19661321
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of colon cancer cell lines to butyrate-mediated proliferation inhibition by combined application of indomethacin and nordihydroguaiaretic acid.
Galfi P; Neogrady Z; Amberger A; Margreiter R; Csordas A
Cancer Detect Prev; 2005; 29(3):276-85. PubMed ID: 15936596
[TBL] [Abstract][Full Text] [Related]
19. Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis.
McMillan L; Butcher S; Wallis Y; Neoptolemos JP; Lord JM
Biochem Biophys Res Commun; 2000 Jun; 273(1):45-9. PubMed ID: 10873561
[TBL] [Abstract][Full Text] [Related]
20. MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.
Husain SS; Szabo IL; Pai R; Soreghan B; Jones MK; Tarnawski AS
Life Sci; 2001 Nov; 69(25-26):3045-54. PubMed ID: 11758830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]